AJP - Heart Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (July 24, 2003). doi:10.1152/ajpheart.00365.2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
285/6/H2578    most recent
00365.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (18)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, Y.
Right arrow Articles by Hofmann, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Y.
Right arrow Articles by Hofmann, P.
Submitted on April 21, 2003
Accepted on July 23, 2003

Acute p38 MAPK activation decreases force development in ventricular myocytes

Yi Chen1, Ravi Rajashree1, Qinghang Liu1, and Polly Hofmann1*

1 Department of Physiology, University of Tennessee, Memphis, TN, USA

* To whom correspondence should be addressed. E-mail: phofmann{at}physio1.utmem.edu.

Evidence suggests p38 MAPK activation influences cardiac function on an acute basis. The characterization and mechanisms by which this occurs was investigated in the present study. Adult rat ventricular myocytes treated with 1 mM arsenite for 30 minutes had a 16 fold increase in p38 MAPK phosphorylation that was attenuated by SB203580 (p38 MAPK inhibitor). ERK and JNK were also minimally activated, but this activation was not sensitive to SB203580. In addition, arsenite caused a p38 MAPK-independent translocation/activation of protein phosphatase 2a (PP2a) and decrease in phosphorylation of myosin light chain 2 (LC2). Arsenite-p38 MAPK activation lead to translocation of heat shock protein 27, but not {alpha}B-crystallin to the myofilaments. Using isolated cardiomyocytes we determined arsenite reduces isometric tension without a change in Ca2+ sensitivity of tension via p38 MAPK, and lowered myofibrillar actomyosin MgATPase activity in a p38 MAPK-independent manner. Thus, arsenite induces a p38 MAPK-independent change in PP2a and LC 2 that may account for the arsenite-dependent decrease in ATPase, and a p38 MAPK-dependent modification of the myofilaments which decrease myocardial force development.




This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
F. Chen, H. Kan, G. Hobbs, and M. S. Finkel
p38 MAP kinase inhibitor reverses stress-induced myocardial dysfunction in vivo
J Appl Physiol, April 1, 2009; 106(4): 1132 - 1141.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Hamdani, V. Kooij, S. van Dijk, D. Merkus, W. J. Paulus, C. d. Remedios, D. J. Duncker, G. J.M. Stienen, and J. van der Velden
Sarcomeric dysfunction in heart failure
Cardiovasc Res, March 1, 2008; 77(4): 649 - 658.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. T. Clements, N. R. Sodha, J. Feng, S. Mieno, M. Boodhwani, B. Ramlawi, C. Bianchi, and F. W. Sellke
Phosphorylation and translocation of heat shock protein 27 and alphaB-crystallin in human myocardium after cardioplegia and cardiopulmonary bypass.
J. Thorac. Cardiovasc. Surg., December 1, 2007; 134(6): 1461 - 1470.e3.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. C. Blunt, A. T. Creek, D. C. Henderson, and P. A. Hofmann
H2O2 activation of HSP25/27 protects desmin from calpain proteolysis in rat ventricular myocytes
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1518 - H1525.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. Vahebi, A. Ota, M. Li, C. M. Warren, P. P. de Tombe, Y. Wang, and R. J. Solaro
p38-MAPK Induced Dephosphorylation of {alpha}-Tropomyosin Is Associated With Depression of Myocardial Sarcomeric Tension and ATPase Activity
Circ. Res., February 16, 2007; 100(3): 408 - 415.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
N. C. Weber, J. Stursberg, N. M. Wirthle, O. Toma, W. Schlack, and B. Preckel
Xenon preconditioning differently regulates p44/42 MAPK (ERK 1/2) and p46/54 MAPK (JNK 1/2 and 3) in vivo
Br. J. Anaesth., September 1, 2006; 97(3): 298 - 306.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Sabri and P. A. Lucchesi
ANG II and cardiac myocyte contractility: p38 is not stressed out!
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H72 - H73.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Palomeque, L. Sapia, R. J. Hajjar, A. Mattiazzi, and M. Vila Petroff
Angiotensin II-induced negative inotropy in rat ventricular myocytes: role of reactive oxygen species and p38 MAPK
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H96 - H106.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Sumida, H. Otani, S. Kyoi, T. Okada, H. Fujiwara, Y. Nakao, M. Kido, and H. Imamura
Temporary blockade of contractility during reperfusion elicits a cardioprotective effect of the p38 MAP kinase inhibitor SB-203580
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2726 - H2734.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
H. Kan, D. Birkle, A. C. Jain, C. Failinger, S. Xie, and M. S. Finkel
p38 MAP kinase inhibitor reverses stress-induced cardiac myocyte dysfunction
J Appl Physiol, January 1, 2005; 98(1): 77 - 82.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1976 by the American Physiological Society.